Provider
QP50-19 Pharmacy Benefit Exclusion for Intramuscular Route of Administration Medications
Program effective Date: Jun 12, 2019
Search Results
Displaying 2531 - 2540 of 3661 results
Provider
QP105-20 Update: EquiClaim to Perform Focused and Limited Hospital Bill Validation (HBV) Services
Program effective Date: Oct 28, 2020
Provider
QP103-20 Commercial Pharmacy Benefit Exclusion for Emtricitabine-Tenofovir Disoproxil Fumarate Tablet 200-300 mg
Program effective Date: Oct 28, 2020
Provider
P83-20 eviCore Healthcare Specialty Utilization Management (UM) Program - Laboratory Management Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers
Program effective Date: Nov 02, 2020
Provider
P77-20 2021 Medicare Product Acupuncture Benefit Changes
Program effective Date: Nov 02, 2020
Provider
QP98-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Fintepla® (fenfluramine) PA with QL
Program effective Date: Oct 14, 2020
Provider
QP101-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) Criteria: Dojolvi™ PA
Program effective Date: Oct 14, 2020
Provider
P69-20 Update Early Intensive Developmental and Behavioral Intervention (EIDBI) Authorization Process
Program effective Date: Sep 01, 2020
Provider
P68-20 Radiology Cardiology Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management (UM) Program
Program effective Date: Sep 01, 2020
Provider
P64-20 Update to the Common Carrier and Special Transportation Services Addendums
Program effective Date: Sep 01, 2020